Suppr超能文献

MMP-9 在孕哺期母鼠高血压或服用阿替洛尔条件下仔鼠切牙中的表达没有改变。

MMP-9 expression in rat pup incisor teeth is not altered by maternal hypertension or maternal atenolol treatment during pregnancy and lactation.

机构信息

Department of Pediatric Dentistry and Public Health, Juiz de Fora Dental School, Universidade Federal de Juiz de Fora- UFJF, Juiz de Fora, MG, Brazil.

Graduate Program in Science, School of Dentistry, São Paulo State University (UNESP), Araçatuba, SP, Brazil.

出版信息

J Mol Histol. 2024 Nov 29;56(1):8. doi: 10.1007/s10735-024-10294-2.

Abstract

Hypertension alters tooth formation and Atenolol reduces the blood pressure of spontaneously hypertensive rats (SHR) during pregnancy and lactation, and as demonstrated before, increases the microhardness of the SHR offspring's teeth. MMP-9 is overexpressed in different tissues of hypertensive animals and treatment of hypertension substances can reverse this alteration. We hypothesize hypertension alters the expression of MMP-9 in dental structures of SHR offspring and that treating female SHR with atenolol prevents this alteration. This study aimed to evaluate the expression of matrix metalloproteinase (MMP-9) in incisor teeth (IT) in male offspring of SHR (30 days old) treated or untreated with Atenolol during pregnancy and lactation. MMP-9 expression was evaluated in ameloblasts (AM), enamel matrix (EM), odontoblasts (OD), and predentin (PD) of IT through immunohistochemical reactions (immunoperoxidase). Data were analyzed by Shapiro-Wilk and Kruskal-Wallis (p < 0.05), with Dunn post-test. Histological differences were not observed between IT tissues of SHR and normotensive Wistar rats. For the first time, our data showed that MMP-9 expression in specific dental structures is not altered in SHR. Atenolol treatment increased MMP-9 immunostaining in EM of Wistar rat, however, Atenolol did not alter MMP-9 in the IT tissues of SHR. Our results demonstrated that MMP-9 expression in dental tissues is not affected by hypertension or atenolol treatment in dental tissues. If confirmed in humans, the results obtained in this study will corroborate the suggestion that MMP-9 is not a viable therapeutic target for the treatment of dental alterations associated with maternal hypertension.

摘要

高血压改变牙齿形成,阿替洛尔在妊娠和哺乳期降低自发性高血压大鼠(SHR)的血压,正如之前所证明的那样,增加了 SHR 后代牙齿的显微硬度。MMP-9 在高血压动物的不同组织中过度表达,而治疗高血压物质可以逆转这种改变。我们假设高血压改变了 SHR 后代牙齿结构中 MMP-9 的表达,并且用阿替洛尔治疗雌性 SHR 可以防止这种改变。本研究旨在评估在妊娠和哺乳期接受或未接受阿替洛尔治疗的 SHR 雄性后代的切牙(IT)中基质金属蛋白酶(MMP-9)的表达。通过免疫组织化学反应(免疫过氧化物酶)评估 MMP-9 在成釉细胞(AM)、釉基质(EM)、成牙本质细胞(OD)和前期牙本质(PD)中的表达。数据通过 Shapiro-Wilk 和 Kruskal-Wallis 进行分析(p<0.05),并进行 Dunn 事后检验。SHR 和正常血压 Wistar 大鼠的 IT 组织之间未观察到组织学差异。我们的数据首次表明,MMP-9 在特定牙齿结构中的表达在 SHR 中没有改变。阿替洛尔治疗增加了 Wistar 大鼠 EM 中的 MMP-9 免疫染色,但阿替洛尔并未改变 SHR 的 IT 组织中的 MMP-9。我们的结果表明,高血压或阿替洛尔治疗不会影响牙齿组织中 MMP-9 的表达。如果在人类中得到证实,本研究的结果将证实 MMP-9 不是治疗与母体高血压相关的牙齿改变的可行治疗靶点的观点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验